Home - Products - Others - Other Targets - 1,4-Bis(diphenylphosphino)butane-palladium(II) chloride

1,4-Bis(diphenylphosphino)butane-palladium(II) chloride

CAS No. 29964-62-3

1,4-Bis(diphenylphosphino)butane-palladium(II) chloride( —— )

Catalog No. M37977 CAS No. 29964-62-3

1,4-Bis(diphenylphosphino)butane-palladium(II) chloride

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 18 In Stock
50MG 22 In Stock
100MG 26 In Stock
200MG 32 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1,4-Bis(diphenylphosphino)butane-palladium(II) chloride
  • Note
    Research use only, not for human use.
  • Brief Description
    1,4-Bis(diphenylphosphino)butane-palladium(II) chloride
  • Description
    1,4-Bis(diphenylphosphino)butane-palladium(II) chloride
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Other Targets
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    29964-62-3
  • Formula Weight
    603.8
  • Molecular Formula
    C28H28P2.Cl2Pd
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Enoblituzumab

    Enoblituzumab is a humanized IgG1 κmab monoclonal antibody that recognizes human B7-H3 protein and can be used to study solid tumors such as non-small cell lung cancer (NSCLC).

  • danshexinkun A

    (+)-danshexinkun A

  • 8-Hydroxyguanosine

    8-hydroxyguanosine (8-OHG) is a marker for measuring the rate of oxidative damage to nucleic acids and lipids.The concentration of 8-OHG in CSF in Parkinson's disease (PD) patients is approximately three-fold that in controls. The concentration of 8-OHG in CSF decreased significantly with the duration of disease. However, the concentration of 8-OHG in serum was not significantly altered in PD patients compared to that in controls.